Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20132670Phase 2Active
A Phase 2 trial of repaglinide in upper respiratory infection (URI), nasopharyngitis, sponsored by Bencao Tiangong. Started Apr 2014; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20132670.